ArticleProceedings of the National Academy of Sciences of the United States of America2013

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.

Rizwan Haq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.